Dr. Borgen on the Prognosis of Male Breast Cancer

Video

Patrick Borgen, MD, discusses the prognosis of breast cancer in male patients.

Patrick Borgen, MD, chair and surgery director of the Breast Cancer Program at Maimonides Medical Center, discusses the prognosis of breast cancer in male patients.

A few years ago, a 3:1 matched pair analysis was conducted at Maimonides Medical Center where investigators controlled for age, stage, and treatment, Borgen says. The investigators found that the prognosis of breast cancer in male patients was identical to that of female patients with the disease, according to Borgen. However, male patients often experience a delay in diagnosis, Borgen adds.

Additionally, a smaller envelope of tissue is noted when comparing the male breast with the female breast. The incidence of nipple or muscle involvement is higher in male patients vs female patients, Borgen says. If these factors can be controlled, the prognosis between male and female patients is similar, Borgen concludes.

Related Videos
Siddartha Yadav, MD, FACP
Nan Chen, MD
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Ko Un “Clara” Park, MD
Erin Frances Cobain, MD
Video 3 - "5-Year Data from the MonarchE Trial Investigating Abemaciclib in HR+, HER2- High-Risk, Early Breast Cancer"
Carlos Arteaga, MD
Video 2 - "NCCN Guidelines vs Real-World Practice: Risk Stratifying HR+/HER2- Early Breast Cancer"